# Kerendia

NDC: 50419-540
Generic name: finerenone
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210709

FDA application: NDA215341

## Active ingredients

- FINERENONE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-540"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-540
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc726765-5d5a-4d6e-b037-b847bda9fb7c